Russia’s focus on domestic pharma production could shield it from sanctions’ effects
Pharmaceutical Technology
JULY 4, 2022
Pharmstandard (Moscow, Russia) and Pharmasyntez (Irkutsk Oblast, Russia) own five facilities each in Russia, the most of any pharma company. The post Russia’s focus on domestic pharma production could shield it from sanctions’ effects appeared first on Pharmaceutical Technology.
Let's personalize your content